Latest round: IPO. John Yu, MD, is the CEO and Chairman of Kairos Pharma, a clinical-stage biopharmaceutical company focused on overcoming cancer drug.
John Yu, MD, is the CEO and Chairman of Kairos Pharma, a clinical-stage biopharmaceutical company focused on overcoming cancer drug resistance and immune suppression. He is also a Professor of Neurosurgery and Director of Neurosurgical Oncology at Cedars-Sinai Medical Center.
Full founder directory · Investor directory · Company funding database · Fundraising library